Logo-jrip

Indexing Information

Scupos

 

Member of

Follower of





 

J Renal Inj Prev. 2016;5(3): 162-167. doi: 10.15171/jrip.2016.34
PMID: 27689115        PMCID: PMC5040005

Original Article

The effect of lactulose supplementation on fecal microflora of patients with chronic kidney disease; a randomized clinical trial

Hamid Tayebi-Khosroshahi 1, Afshin Habibzadeh 2, Bahram Niknafs 1, Reza Ghotaslou 1, Fatemeh Yeganeh Sefidan 1, Morteza Ghojazadeh 1, Majid Moghaddaszadeh 1, Sahar Parkhide 1

Cited by CrossRef: 47

1- Chung S, Barnes J, Astroth K. Gastrointestinal Microbiota in Patients with Chronic Kidney Disease: A Systematic Review. Advances in Nutrition. 2019;10(5):888 [Crossref]
2- Liu C, Yang L, Wei W, Fu P. Efficacy of probiotics/synbiotics supplementation in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. Front Nutr. 2024;11 [Crossref]
3- Wehedy E, Shatat I, Al Khodor S. The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword. Front Med. 2022;8 [Crossref]
4- Manish S, Jony A, Shahzad A, Amit G. Role of Dietary Fibers in Chronic Kidney Disease Patients. 2023;8(1):6 [Crossref]
5- Sumida K, Lau W, Kovesdy C, Kalantar-Zadeh K, Kalantar-Zadeh K. Microbiome modulation as a novel therapeutic approach in chronic kidney disease. 2021;30(1):75 [Crossref]
6- Yang H, Feng P, Xu Y, Hou Y, Ojo O, Wang X. The Role of Dietary Fiber Supplementation in Regulating Uremic Toxins in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials. Journal of Renal Nutrition. 2021;31(5):438 [Crossref]
7- Sumida K, Yamagata K, Kovesdy C. Constipation in CKD. Kidney International Reports. 2020;5(2):121 [Crossref]
8- Ruszkowski J, Witkowski J. Lactulose: Patient- and dose-dependent prebiotic properties in humans. Anaerobe. 2019;59:100 [Crossref]
9- Tayebi Khosroshahi H, Vaziri N, Abedi B, Asl B, Ghojazadeh M, Jing W, Vatankhah A. Effect of high amylose resistant starch (HAM‐RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial. Hemodialysis International. 2018;22(4):492 [Crossref]
10- Jayasekhar Babu P, Tirkey A, Mohan Rao T, Chanu N, Lalchhandama K, Singh Y. Conventional and nanotechnology based sensors for creatinine (A kidney biomarker) detection: A consolidated review. Analytical Biochemistry. 2022;645:114622 [Crossref]
11- Cha R, Park S, Camilleri M. Constipation in Patients With Chronic Kidney Disease. J Neurogastroenterol Motil. 2023;29(4):428 [Crossref]
12- Sumida K, Pierre J, Yuzefpolskaya M, Colombo P, Demmer R, Kovesdy C. Gut Microbiota-Targeted Interventions in the Management of Chronic Kidney Disease. Seminars in Nephrology. 2023;43(2):151408 [Crossref]
13- Narimani R, Esmaeili M, Rasta S, Khosroshahi H, Mobed A. Trend in creatinine determining methods: Conventional methods to molecular‐based methods. Analytical Science Advances. 2021;2(5-6):308 [Crossref]
14- Vijay A, Valdes A. RETRACTED ARTICLE: Role of the gut microbiome in chronic diseases: a narrative review. Eur J Clin Nutr. 2022;76(4):489 [Crossref]
15- Pantazi A, Kassim M, Nori W, Tuta L, Mihai C, Chisnoiu T, Balasa A, Mihai L, Lupu A, Frecus C, Lupu V, Chirila S, Badescu A, Hangan L, Cambrea S. Clinical Perspectives of Gut Microbiota in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: Where Do We Stand?. Biomedicines. 2023;11(9):2480 [Crossref]
16- Nata N, Suebsiripong S, Satirapoj B, Supasyndh O, Chaiprasert A. Efficacy of Lactulose versus Senna Plus Ispaghula Husk Among Patients with Pre-Dialysis Chronic Kidney Disease and Constipation: A Randomized Controlled Trial. IJNRD. 2021;Volume 14:313 [Crossref]
17- Ebrahim Z, Glorieux G, Moosa M, Blaauw R. Effect of simplified dietary advice on nutritional status and uremic toxins in chronic kidney disease participants. South African Journal of Clinical Nutrition. 2022;35(4):168 [Crossref]
18- Ondrussek-Sekac M, Navas-Carrillo D, Orenes-Piñero E. Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components. Critical Reviews in Food Science and Nutrition. 2021;61(9):1490 [Crossref]
19- Yalçın B, Özgen Özkaya Ş. Kronik Böbrek Hastalıklarında Prebiyotik Kullanımının Hastalık Progresyonu Üzerine Etkileri. 2024;(23):968 [Crossref]
20- Chandra M, Paray A. General and microbiological chronic diseases into humans. Int J Sci Rep. 2024;10(10):375 [Crossref]
21- Zhao M, Saab S, Craw C, Lee E. The Impact of Renal Function on Hepatic Encephalopathy Following TIPS Placement for Refractory Ascites. Biomedicines. 2023;11(8):2171 [Crossref]
22- Mafra D, Borges N, Lindholm B, Shiels P, Evenepoel P, Stenvinkel P. Food as medicine: targeting the uraemic phenotype in chronic kidney disease. Nat Rev Nephrol. 2021;17(3):153 [Crossref]
23- Yoshida K, Hirano R, Sakai Y, Choi M, Sakanaka M, Kurihara S, Iino H, Xiao J, Katayama T, Odamaki T. Bifidobacterium response to lactulose ingestion in the gut relies on a solute-binding protein-dependent ABC transporter. Commun Biol. 2021;4(1) [Crossref]
24- Drozdov V, Shikh E, Astapovskiy A, Serebrova S, Komissarenko I. Modern opportunities of pharmacological effect on gut microbiome and motor activity. Medicinskij sovet. 2021;(12):200 [Crossref]
25- Sumida K, Lau W, Kalantar-Zadeh K, Kovesdy C. Novel intestinal dialysis interventions and microbiome modulation to control uremia. 2022;31(1):82 [Crossref]
26- Chu N, Ling J, Jie H, Leung K, Poon E. The potential role of lactulose pharmacotherapy in the treatment and prevention of diabetes. Front Endocrinol. 2022;13 [Crossref]
27- Ranganathan N, Anteyi E. The Role of Dietary Fiber and Gut Microbiome Modulation in Progression of Chronic Kidney Disease. Toxins. 2022;14(3):183 [Crossref]
28- Tian N, Li L, Ng J, Li P. The Potential Benefits and Controversies of Probiotics Use in Patients at Different Stages of Chronic Kidney Disease. Nutrients. 2022;14(19):4044 [Crossref]
29- Mi K, Jiang Y, Chen J, Lv D, Qian Z, Sun H, Shang D. Construction and Analysis of Human Diseases and Metabolites Network. Front Bioeng Biotechnol. 2020;8 [Crossref]
30- Cho Y, Lee Y, Shin J, Jung H, Park S, Kang S, Song K, Kim J, Lim H, Park H, Kim S, Cha R, Bang K, Bang C, Yim S, Ryoo S, Kye B, Ji W, Choi M, Sung I, Choi S. 2022 Seoul Consensus on Clinical Practice Guidelines for Functional Constipation. J Neurogastroenterol Motil. 2023;29(3):271 [Crossref]
31- Kim K, Kim J, Kim J, Ahn S, Jung C, Hwang S, Lee S, Song J. Real-world evidence of constipation and laxative use in the Korean population with chronic kidney disease from a common data model. Sci Rep. 2024;14(1) [Crossref]
32- Bush J, Han J, Deehan E, Harding S, Maiya M, Baisley J, Schibli D, Goodlett D. Resistant potato starch supplementation reduces serum histamine levels in healthy adults with links to attenuated intestinal permeability. Journal of Functional Foods. 2023;108:105740 [Crossref]
33- Saxami G, Kerezoudi E, Eliopoulos C, Arapoglou D, Kyriacou A. The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics. Life. 2023;13(10):2023 [Crossref]
34- Mafra D, Borges N, Alvarenga L, Esgalhado M, Cardozo L, Lindholm B, Stenvinkel P. Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease. Nutrients. 2019;11(3):496 [Crossref]
35- Cooper T, Khalid R, Chan S, Craig J, Hawley C, Howell M, Johnson D, Jaure A, Teixeira-Pinto A, Wong G. Synbiotics, prebiotics and probiotics for people with chronic kidney disease. 2023;2023(10) [Crossref]
36- Ebrahim Z, Proost S, Tito R, Raes J, Glorieux G, Moosa M, Blaauw R. The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial. Nutrients. 2022;14(4):805 [Crossref]
37- Wang H, Lee J. Pharmacologic Treatment of Chronic Constipation. Korean J Gastroenterol. 2024;83(5):184 [Crossref]
38- Rukavina Mikusic N, Kouyoumdzian N, Choi M. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis. Pflugers Arch - Eur J Physiol. 2020;472(3):303 [Crossref]
39- de Andrade L, Ramos C, Cuppari L. The cross-talk between the kidney and the gut: implications for chronic kidney disease. Nutrire. 2017;42(1) [Crossref]
40- Wotzka S, Kreuzer M, Maier L, Zünd M, Schlumberger M, Nguyen B, Fox M, Pohl D, Heinrich H, Rogler G, Biedermann L, Scharl M, Sunagawa S, Hardt W, Misselwitz B, Staley C. Microbiota stability in healthy individuals after single-dose lactulose challenge—A randomized controlled study. PLoS ONE. 2018;13(10):e0206214 [Crossref]
41- Wan M, King L, Baugh N, Arslan Z, Snauwaert E, Paglialonga F, Shroff R. Gutted: constipation in children with chronic kidney disease and on dialysis. Pediatr Nephrol. 2023;38(11):3581 [Crossref]
42- Pranami D, Sharma R, Pathak H. Lactulose: a prebiotic, laxative and detoxifying agent. Drugs Ther Perspect. 2017;33(5):228 [Crossref]
43- Khorasani S, Mahmoudi M, Kalantari M, Lavi Arab F, Esmaeili S, Mardani F, Tabasi N, Rastin M. Amelioration of regulatory T cells by Lactobacillus delbrueckii and Lactobacillus rhamnosus in pristane‐induced lupus mice model. Journal Cellular Physiology. 2019;234(6):9778 [Crossref]
44- Cabała S, Ożgo M, Herosimczyk A. The Kidney–Gut Axis as a Novel Target for Nutritional Intervention to Counteract Chronic Kidney Disease Progression. Metabolites. 2024;14(1):78 [Crossref]
45- Zupcic A, Slezak P, Radloff J. The Gastrointestinal Microbiota as a Potential Cause and Target in Chronic Kidney Disease Accentuating Treatment and Intervention Strategies. Applied Sciences. 2023;13(5):3212 [Crossref]